mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |